Study analyzes two different classes of drugs in a large group of preschoolers with ADHD

In a multi-institutional study, researchers in the Developmental-Behavioral Pediatrics Research Network (DBPNet), led by Children's Hospital of Philadelphia (CHOP), have conducted the first and largest analysis to date comparing the effectiveness and side effects of stimulants like methylphenidate (Ritalin) and alpha-adrenergic agonists like guanfacine (Tenex) in preschool-age children. The researchers found that both classes of […]

Inflammation linked to intensity of tobacco smoking among HIV-positive people

Inflammation in the body has been linked to the intensity of tobacco smoking among people with HIV, according to a team of University of Massachusetts Amherst researchers. Krishna Poudel, associate professor of community health education in the School of Public Health and Health Sciences, and colleagues reported positive linear relationships between intensity, duration and pack-years […]

Using Webinars to Tell Science Stories – PART II

Image Credit: This is me/Shutterstock.com Subscribe | Spotify | Stitcher | Apple | iHeartRadio | Mobile | Download Part I discussed the benefits of using webinars and what it takes to create the finished product. In Part II, we carry on our conversation with Andy Henton, Founder and Director of InsideScientific, and dive a little […]

Trileptal

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TRILEPTAL® oxcarbazepine Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Trileptal. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in […]

Test document

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ARANESP® darbepoetin alfa Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about Aranesp (darbepoetin alfa). It does not contain all the available information. It does not take the place of talking to your doctor, nurse […]

Lamivudine + Zidovudine Alphapharm

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LAMIVUDINE 150 MG + ZIDOVUDINE 300 MG ALPHAPHARM lamivudine and zidovudine CONSUMER MEDICINE INFORMATION What is in this leaflet Please read this leaflet carefully before you start LAMIVUDINE 150mg + ZIDOVUDINE 300mg Alphapharm. This leaflet answers some common questions about LAMIVUDINE 150mg […]

Emgality

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. EMGALITY® This medicine is subject to additional monitoring. This will allow quick identificationof new safety information. You can help by reporting any side effects you may get.You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.   Prefilled Pen (Autoinjector) […]

Perindo Combi

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PERINDO® COMBI 4/1.25 perindopril (pronounced per-in-do-pril) and indapamide (pronounced in-dap-a-mide) Consumer Medicine Information WHAT IS IN THIS LEAFLET This leaflet answers some common questions about PERINDO COMBI 4/1.25. It does not contain all the available information about this medicine. Reading this leaflet […]